To evaluate the effect ofempiricintralipidinfusion therapy on pregnancy outcomes in patient withunexplained recurrentimplantation failure (RIF) undergoIntracytoplasmic sperm injection (ICSI).

the aim to evaluate the effect ofempiricintralipidinfusion therapy on pregnancy outcomes in patient withunexplained recurrentimplantation failure (RIF) undergoIntracytoplasmic sperm injection (ICSI).

A total of 142 patients with history of unexplained RIF3 or more cycles were included in the study. Patient were randomized into two groups, study group (n=71) and control group (n=71). The study groupreceivedintralipid 20%infusionon the day of embryo transfer (ET) and a second dose on the day of pregnancy test. The control group underwent ET without intralipidinfusion.Allpatientswereclosely monitored for any side effectsincluding allergic reactions.

Inclusion Criteria:

• age < 42 years
• BMI < 30 kg/m2
• history of 3 or more recurrent implantation failure undergoing Intracytoplasmic Sperm Injection (ICSI ) cycle.

exclusion criteria

• women with medical contraindications of intralipidinfusion.
• uterine fibroid.
• endometrial polyp.
• endometriosis,hydrosalpinx.
• intrauterine adhesion and uterine anomalies.
• Women with positive thrombophilia screen.
• diminished ovarian reserve.
• severe male factor infertility .
• chronic medical illnesses which may contribute in impaired chance of pregnancy .

biologicaly female